In January 2018 researchers from Israel published the results of their study to assess the effectiveness, safety and tolerability of medical cannabis in children with complex motor disorders. Two cannabis oil products were compared in 25 patients, aged 1-17 years, with complex motor disorders with the assigned cannabis oil being administered for a five month period. Results showed that there was a significant improvement in spasticity and dystonia, sleep difficulties, pain severity, and Quality of Life in all patients, irrespective of which cannabis oil they received. Adverse effects were rare but included worsening of seizures in two patients, behavioural changes in two and increased sleepiness in one.
Libzon S et al. Medical Cannabis for Pediatric Moderate to Severe Complex Motor Disorders. J Child Neurol. 2018 Jan 1: [Epub ahead of print]